GCRF Establishment of biopharmaceutical and animal vaccine production capacity in Thailand and neighbouring SE Asian countries
Lead organisation: University of Kent
LSHTM staff : Prof Richard Coker , Dr.Fatim Lakha
Collaborating organisations: LSHTM, UCL, BIOTEC, Imperial College London, National Biopharmaceutical Facility
Support by: GCRF – Global Challenges Research Fund
To produce life-saving Biopharmaceuticals in Thailand for the first time at a cost that allows wide access to patients.
To produce a suite of veterinary vaccines against the major porcine disease that will be made available to farms in Thailand, resulting in a sustained reduction in livestock losses.
To establish state of the art technical capacity for recombinant protein production by Thai groups, which can be expanded upon and consolidated for future growth.
To give neighbouring SE Asian countries full access to the programme’s technology and expertise in order to effectively plan similar ventures.
This project brings together Thai groups at the forefront of the country’s new programme to produce recombinant proteins, UK groups that have developed state of the art E. coli- and CHO cell-based expressed systems as well as down-stream processing and analytic tools, and Bangkok-based UK specialists in SE Asian healthcare, economic policies and dissemination tools.
This work is funded by the Global Challenges Research Fund and will contribute towards several UN Sustainable Development Goals:
Good health and well-being
Industry, innovation and infrastructure
Please visit the website here.